Nectar Lifesciences Limited
Share Price Target & Analysis

NSE:NECLIFE

11.87

VWAP

12.2

Open

12.06

Close

12.2

High

11.7

Low

28.25

52 Week High

11.79 ⇩
-0.27 (-2.24%)

NECLIFE

(PHARMA)
13.1% Momentum

Turnaround Potential

9.3

52 Week Low

N/A

EPS

40.62

PE

0.36

PB

Uncertain
Quality

Unclear
Valuation

#Analysis

NSE: NECLIFE Share Price Financial Analysis & Valuation

Nectar Lifesciences Limited (NECLIFE) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Micro Cap company with Market Capitalization of Rs 734.5 (in Cr). Total number of free float shares are 22.4 (in Lacs). Nectar Lifesciences Limited is listed on NSE with Exchange ID - INE023H01027 and trading code is NSE:NECLIFE with short name Nectar Life.

In the past 1 year, Nectar Lifesciences Limited has declared an equity dividend of Rs 0 per share. At the current share price of NECLIFE at Rs 11.79, this results in a dividend yield of 0 %.

As per the Fundamental Analysis of NSE:NECLIFE, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine NECLIFE underlying value and future prospects. All of this data is available in NECLIFE financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:NECLIFE, it is clearly understood that NECLIFE is Uncertain performer in terms of earnings and profit margins with an EPS of 0. NSE:NECLIFE book value per share as of today is 32.6. The current price to book ratio for NECLIFE as of Apr 25, 2026 is 0.36.

Valuation of the Stock: The current valuation of NECLIFE stock is like Unclear which means currently the stock is Confusing. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of NECLIFE whether to BUY this stock at current valuation. The delivery percentage of NECLIFE is 49.33% is very crucial parameter which shows that 49.33% investors are anticipating that the price of NECLIFE share should go up with VWAP at 11.87.

Now, the main question is whether to BUY or SELL, NSE:NECLIFE at current valuation.
As per latest Analysis No. #2899:-

⇑ STRONG BUY NECLIFE if All Greens

⇗ BUY NECLIFE (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD NECLIFE (With Stop Loss) if only 1 Green

⇘ SELL NECLIFE if NO Green Indicator

NSE: NECLIFE Share Price Today (Apr 25, 2026)

(Nectar Lifesciences Limited Daily Analysis on the basis of NECLIFE Intraday Graph & Trend)

Nectar Lifesciences Limited share price moved Down by -2.24% from its previous close of Rs 12.06. NECLIFE stock last traded price is 11.79. NECLIFE share price trend is Down with a total of 307341 stocks traded till now. It has touched an intraday high of Rs 12.2 and an intraday low of Rs 11.7. The NECLIFE trading at 11.79, Down by Rs. -0.27, or -2.24 percent which suggests that most of the Traders are anticipating that the price of NECLIFE share should go Down.

NSE: NECLIFE Share Price Tomorrow Prediction

(Nectar Lifesciences Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of NECLIFE)

Nectar Lifesciences Limited share price moved Down by -2.24%. NECLIFE share price short term trend is Down. It suggests that NECLIFE Share Price for Tomorrow remains the same with VWAP at 11.87 will be treated as stop loss for intraday traders. Nectar Lifesciences Limited Long term investors can follow the NECLIFE long term trend as mentiond in future forecast table.

NSE Code

NSE: NECLIFE

NECLIFE Share Price Today

 11.79

NECLIFE Share Price Target Prediction for 2026 ^

 9.8 - 20

NECLIFE Share Price Target Prediction for 2027*^

 20 - 20.8

NECLIFE Share Price Target Prediction for 2028*^

 20.8 - 21.8

NECLIFE Share Price Target Prediction for 2029*^

 23

NECLIFE Share Price Target Prediction for 2030*^

 23

NECLIFE Share Price Target Prediction for 2035*^

 25
NECLIFE Current Book Value 2025
32.4

*Nectar Lifesciences Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^NECLIFE share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

NECLIFE Technical Analysis

Candlestick Pattern: @19.88

NECLIFE Moving Averages

BUY (2) NEUTRAL (0) SELL (12)
MA Simple Action S1 Expo Action E2
MA_5 19.49 BUY 19.74 BUY
MA_12 21.41 SELL 20.86 SELL
MA_20 21.53 SELL 21.44 SELL
MA_32 22.92 SELL 22.15 SELL
MA_50 22.95 SELL 22.8 SELL
MA_100 23.42 SELL 24.56 SELL
MA_200 30.72 SELL 28.1 SELL

NECLIFE Trend Oscillators

BUY (0) NEUTRAL (1) SELL (3)
Trend Oscillators Value Action
Bollinger Bands 21.53 Downtrend
MACD -0.32 SELL
ADX 16.11 NO or Weak Trend
DMI (+/-) 24.2 / 34.9 Downtrend

NECLIFE Momentum Oscillators

BUY (2) NEUTRAL (8) SELL (2)
Momentum Oscillators Value Action
RSI 42.64 Neutral
STOCHASTIC_K (Fast) 50.56 Neutral
STOCHASTIC_D (Slow) 31.38 Neutral
CCI -59.3 Neutral
PSAR 23.12 SELL
TRUE RANGE 1.41 BUY
ATR 1.67 BUY
WILLIAMS R -47.73 Neutral
TRIX 0 Neutral
STOCHASTIC RSI K 65.41 Neutral
STOCHASTIC RSI D 41.32 Neutral
MOMENTUM -3.98 SELL

NECLIFE Last 1 Year Trend

Duration Value
1 Year -35.91%
3 Months -10.65%
1 Month -16.68%
1 Week -12.38%

NECLIFE Technical Analysis Summary

Updated on 2025-07-11
Action Overall (%)
BUY 13%
NEUTRAL / HOLD 30%
SELL 57%

Most popular Questions & Answers about NECLIFE


Nectar Lifesciences Limited stock last traded price is 11.79. NECLIFE share price moved Down by -2.24% from its previous close of Rs 12.06.

Nectar Lifesciences Limited share price trend is Down with a total of 307341 stocks traded till now. It has touched an intraday high of Rs 28.5325 and an intraday low of Rs 11.7. The NECLIFE trading at 11.79, Down by Rs. -0.27, or -2.24 percent which suggests that most of the Traders are anticipating that the price of NECLIFE share should go Down and the Stop Loss will be around 11.87.

The market cap of Nectar Lifesciences Limited is ₹734.5 (in Cr) as of Apr 24, 2026.

The current price to earning ratio for Nectar Lifesciences Limited as of Apr 24, 2026 is 40.62.

The current price to book ratio for Nectar Lifesciences Limited as of Apr 24, 2026 is 0.36.

The highest price of Nectar Lifesciences Limited stock is ₹28.25 in the last 52-week.

The lowest price of Nectar Lifesciences Limited stock is ₹9.3 in the last 52-week.

Nectar Lifesciences Limited share trading at ₹11.79, Down by Rs. -0.27, or -2.24 percent which suggests that most of the traders are anticipating that the price of NECLIFE share should go Down.

In 2025, Stock price target for Nectar Lifesciences Limited (NECLIFE) are ₹9.8 on downside and ₹20 on upside. Nectar Lifesciences Limited share price target is based on current financial year earings of the company.

In 2026, Stock price target for Nectar Lifesciences Limited (NECLIFE) are ₹20 on downside and ₹20.8 on upside. Nectar Lifesciences Limited share price target is based on forecasted future earnings of the company.

In 2027, Stock price target for Nectar Lifesciences Limited (NECLIFE) are ₹20.8 on downside and ₹21.8 on upside. Nectar Lifesciences Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Nectar Lifesciences Limited (NECLIFE) will be around ₹23 Nectar Lifesciences Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of NECLIFE.

The price of Nectar Lifesciences Limited (NECLIFE) shares moved by -2.24%. The short-term trend for NECLIFE share price is Down. It implies that the share price of NECLIFE will stay the same tomorrow and that intraday traders should treat VWAP at 11.87 as a stop loss. Investors with a long-term outlook can track NECLIFE long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of NECLIFE stock is Unavailable at this moment. Compared to the current market price of 11.79 INR, the NECLIFE stock is unpredictable by lack of Insufficient data.

As per the fundamental analysis of Nectar Lifesciences Limited (NECLIFE), it is of Uncertain quality in terms of earnings and profit margins with an EPS of 0. Nectar Lifesciences Limited book value per share as of today is 32.6. The current price to book ratio for NECLIFE as of Apr 25, 2026 is 0.36.


NSE:NECLIFE News & Other Useful Information about NECLIFE Share Price


Peer Comparison of NSE: NECLIFE

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1620.40 16.77 102.19
DIVISLAB 6361.50 94.85 600.79
MEDICAMEQ 257.66 6.52 202.47
CIPLA 1295.00 57.14 419.19
DRREDDY 1317.10 55.59 378.64
PGHH 5215.00 189.8 373.34
TORNTPHARM 4117.20 64.97 266.87
BIOCON 349.85 0.05 99.01
LUPIN 2296.10 120.18 611.19
ALKEM 5235.00 195.87 1194.91
Updated at: 24 Apr 2026 15:58

Feel free to contact us, in case of any queries.

SITEMAP 7223
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2287.60 -12.40 (-0.54%) | ADANIGREEN 1235.80 21.65 (1.78%) | ADANIPORTS 1585.10 -17.80 (-1.11%) | ADANITRANS 988.50 0.35 (0.04%) | AMBUJACEM 451.20 0.80 (0.18%) | APOLLOHOSP 7732.50 -48.50 (-0.62%) | ASIANPAINT 2485.10 -36.30 (-1.44%) | ATGL 626.85 5.15 (0.83%) | AUROPHARMA 1413.80 -21.60 (-1.5%) | AXISBANK 1365.90 -3.70 (-0.27%) | BAJAJ-AUTO 9576.00 25.50 (0.27%) | BAJAJFINSV 1770.70 -21.90 (-1.22%) | BAJFINANCE 921.55 3.20 (0.35%) | BALKRISIND 2225.40 -40.00 (-1.77%) | BANDHANBNK 174.67 0.77 (0.44%) | BANKBARODA 274.13 -2.21 (-0.8%) | BEL 444.45 -5.50 (-1.22%) | BERGEPAINT 460.40 -8.25 (-1.76%) | BHARTIARTL 1814.50 -26.70 (-1.45%) | BIOCON 349.85 -8.15 (-2.28%) | BOSCHLTD 36690.00 -690.00 (-1.85%) | BPCL 308.10 -1.70 (-0.55%) | BRITANNIA 5730.50 59.00 (1.04%) | CADILAHC 905.25 2.35 (0.26%) | CIPLA 1295.00 -10.90 (-0.83%) | COALINDIA 456.00 5.35 (1.19%) | COLPAL 2171.30 21.10 (0.98%) | DABUR 451.10 -8.90 (-1.93%) | DIVISLAB 6361.50 -17.00 (-0.27%) | DLF 587.05 -5.75 (-0.97%) | DMART 4443.50 -77.70 (-1.72%) | DRREDDY 1317.10 -13.90 (-1.04%) | EICHERMOT 7111.50 19.00 (0.27%) | GAIL 165.61 0.65 (0.39%) | GLAND 1713.50 -81.90 (-4.56%) | GODREJCP 1089.90 -53.05 (-4.64%) | GRASIM 2739.30 4.30 (0.16%) | GUJGASLTD 383.85 -2.15 (-0.56%) | HAVELLS 1238.60 -21.70 (-1.72%) | HCLTECH 1203.20 -74.40 (-5.82%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 2735.00 26.80 (0.99%) | HDFCBANK 784.85 0.50 (0.06%) | HDFCLIFE 588.20 -10.45 (-1.75%) | HEROMOTOCO 4961.50 -70.50 (-1.4%) | HINDALCO 1048.35 7.00 (0.67%) | HINDUNILVR 2327.30 -39.10 (-1.65%) | HINDZINC 588.50 -3.60 (-0.61%) | ICICIBANK 1326.20 -21.80 (-1.62%) | ICICIGI 1772.10 -37.80 (-2.09%) | ICICIPRULI 514.20 -21.10 (-3.94%) | INDIGO 4523.10 -32.90 (-0.72%) | INDUSINDBK 847.95 -12.40 (-1.44%) | INDUSTOWER 402.20 -2.50 (-0.62%) | INFY 1154.60 -86.00 (-6.93%) | IOB 35.01 -0.13 (-0.37%) | IOC 143.47 -2.01 (-1.38%) | ITC 301.60 -3.70 (-1.21%) | JSWSTEEL 1255.70 -1.30 (-0.1%) | KOTAKBANK 370.85 0.45 (0.12%) | LT 4014.30 -39.80 (-0.98%) | LTI 5706.50 -337.50 (-5.58%) | LUPIN 2296.10 -45.30 (-1.93%) | M&M 3038.40 -9.30 (-0.31%) | MARICO 783.30 4.40 (0.56%) | MARUTI 13048.00 -112.00 (-0.85%) | MCDOWELL-N 1358.10 -8.00 (-0.59%) | MOTHERSUMI 121.00 -1.62 (-1.32%) | MUTHOOTFIN 3493.50 -67.90 (-1.91%) | NAUKRI 984.95 -33.10 (-3.25%) | NESTLEIND 1421.30 10.80 (0.77%) | NMDC 89.29 1.98 (2.27%) | NTPC 401.85 -0.40 (-0.1%) | ONGC 284.80 -1.45 (-0.51%) | PEL 1124.20 0.00 (0%) | PIDILITIND 1394.30 -7.80 (-0.56%) | PIIND 3081.20 11.60 (0.38%) | PNB 113.09 0.38 (0.34%) | POWERGRID 316.40 -2.75 (-0.86%) | RELIANCE 1327.80 -15.60 (-1.16%) | SAIL 178.46 2.01 (1.14%) | SBICARD 670.30 -10.25 (-1.51%) | SBILIFE 1768.90 -59.20 (-3.24%) | SBIN 1101.10 6.85 (0.63%) | SHREECEM 24950.00 -520.00 (-2.04%) | SIEMENS 3808.90 -55.50 (-1.44%) | SRF 2493.60 -48.80 (-1.92%) | SUNPHARMA 1620.40 -59.70 (-3.55%) | TATACONSUM 1174.00 -10.40 (-0.88%) | TATAMOTORS 375.45 3.40 (0.91%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 210.07 -0.84 (-0.4%) | TCS 2396.90 -124.90 (-4.95%) | TECHM 1358.50 -63.00 (-4.43%) | TITAN 4410.00 -46.50 (-1.04%) | TORNTPHARM 4117.20 -30.00 (-0.72%) | ULTRACEMCO 11998.00 -169.00 (-1.39%) | UPL 631.40 -10.65 (-1.66%) | VEDL 720.95 -14.65 (-1.99%) | WIPRO 199.36 -3.40 (-1.68%) |